Advanced CANCER Therapies

life is precious

Striving for a better future, Silenseed is dedicated towards developing drugs and drug delivery platforms that create a novel treatment for solid tumors. Harnessing new scientific horizons, we are developing solutions for untreated cancers and innovative ways for RNAi drug delivery.

Inside Silenseed

Revolutionary cancer therapies

icon doctor

Clinical Trial's

Phase II Clinical Trial for Pancreatic Cancer –
Currently available for stage 3 patients
For more details

dna

RNAI delivery

Motivated by the challenges facing RNAi delivery, Silenseed has developed a novel drug delivery platform – LODER™ (LOcal Drug EluteR), which enables the insertion of RNAi therapeutic pharmaceuticals directly into the core of solid tumors

ribbon2

Patient Care

With patients in mind – Silenseed is dedicated towards developing novel drugs that harness new scientific horizons developing solutions for untreated cancers 

silenseed-rnai-labs

Inside Silenseed

Clinical Updates

KRAS-LODER Reaches Undruggable Targets